Therapy Areas: AIDS & HIV
18 July 2018 - Spruce Biosciences, a clinical-stage biotechnology company developing novel therapies for rare endocrine disorders, including its lead program for congenital adrenal hyperplasia (CAH), ...
16 July 2018 - - Mississauga, Ontario-based research biopharmaceutical company Gilead Canada, a subsidiary of global Gilead Sciences, Inc. (NASDAQ: GILD), was granted a notice of compliance by Health ...
28 June 2018 - - Hangzhou, China-based biotechnology company Ascletis has signed a strategic cooperation agreement with CR Pharmaceutical Commercial Group to prepare for the launch of Ascletis' G...
25 June 2018 - Abiwax (Paris:ABVX), a biotechnology company, announced on Friday the appointment of Professor Ian McGowan, MD, PhD, a current scientific advisory board (SAB) member, as chair of the SA...
20 June 2018 - Plasma medicine company Grifols (MCE:GRF) MCE:GRF.P) (NASDAQ:GRFS) disclosed on Tuesday the receipt of approval from the US Food & Drug Administration (FDA) for two blood screening ...
18 June 2018 - United Kingdom-based ViiV Healthcare has reported that two phase three trials assessing the two-drug regimen (2DR) of dolutegravir (Tivicay) and lamivudine (Epivir) in treatment naive H...